1,2-dichloroethane increases expression ISO RGD:1621608 6480464 ethylene dichloride results in increased expression of MEF2A mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions EXP 6480464 [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in increased expression of MEF2A mRNA CTD PMID:27840820 1,2-dimethylhydrazine decreases expression ISO RGD:1621608 6480464 1, 2-Dimethylhydrazine results in decreased expression of MEF2A mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of MEF2A mRNA CTD PMID:29097150 17beta-estradiol affects expression ISO RGD:1621608 6480464 Estradiol affects the expression of MEF2A mRNA CTD PMID:15598610 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of MEF2A mRNA CTD PMID:32145629 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1322126 6480464 Dihydrotestosterone results in increased expression of MEF2A mRNA CTD PMID:16631469 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1621608 6480464 Tetrachlorodibenzodioxin results in increased expression of MEF2A mRNA CTD PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MEF2A mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MEF2A mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1322126 6480464 Tetrachlorodibenzodioxin results in increased expression of MEF2A mRNA CTD PMID:20106945 more ... 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO RGD:1322126 6480464 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA] more ... CTD PMID:20165829 2-amino-2-deoxy-D-glucopyranose decreases expression EXP 6480464 Glucosamine results in decreased expression of MEF2A mRNA, Glucosamine results in decreased expression of MEF2A protein CTD PMID:20165829 2-amino-2-deoxy-D-glucopyranose decreases expression ISO RGD:1322126 6480464 Glucosamine results in decreased expression of MEF2A mRNA, Glucosamine results in decreased expression of MEF2A protein CTD PMID:20165829 2-amino-2-deoxy-D-glucopyranose multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA] more ... CTD PMID:20165829 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1621608 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of MEF2A mRNA CTD PMID:20188158 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1621608 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of MEF2A mRNA CTD PMID:26251327 4-phenylbutyric acid multiple interactions ISO RGD:1322126 6480464 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA], 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein] CTD PMID:20165829 4-phenylbutyric acid multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA], 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein] CTD PMID:20165829 5-azacytidine increases expression ISO RGD:1621608 6480464 Azacitidine results in increased expression of MEF2A CTD PMID:12094073 5-azacytidine affects expression ISO RGD:1621608 6480464 Azacitidine affects the expression of MEF2A protein CTD PMID:19002953 acrolein multiple interactions ISO RGD:1322126 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of MEF2A mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of MEF2A mRNA CTD PMID:32699268 acrylamide increases expression ISO RGD:1322126 6480464 Acrylamide results in increased expression of MEF2A mRNA CTD PMID:32763439 aflatoxin B1 increases methylation ISO RGD:1322126 6480464 Aflatoxin B1 results in increased methylation of MEF2A gene CTD PMID:28458013 aldehydo-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of MEF2A mRNA, Glucosamine results in decreased expression of MEF2A protein CTD PMID:20165829 aldehydo-D-glucosamine decreases expression ISO RGD:1322126 6480464 Glucosamine results in decreased expression of MEF2A mRNA, Glucosamine results in decreased expression of MEF2A protein CTD PMID:20165829 aldehydo-D-glucosamine multiple interactions ISO RGD:1322126 6480464 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA] more ... CTD PMID:20165829 aldehydo-D-glucosamine multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA] more ... CTD PMID:20165829 alpha-pinene multiple interactions ISO RGD:1322126 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of MEF2A mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of MEF2A mRNA CTD PMID:32699268 arsenite(3-) multiple interactions ISO RGD:1322126 6480464 arsenite inhibits the reaction [G3BP1 protein binds to MEF2A mRNA] CTD PMID:32406909 benzene increases expression ISO RGD:1322126 6480464 Benzene results in increased expression of MEF2A mRNA CTD PMID:33064461 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1322126 6480464 7 more ... CTD PMID:19150397 , PMID:20018196 beta-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of MEF2A mRNA, Glucosamine results in decreased expression of MEF2A protein CTD PMID:20165829 beta-D-glucosamine multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA] more ... CTD PMID:20165829 beta-D-glucosamine decreases expression ISO RGD:1322126 6480464 Glucosamine results in decreased expression of MEF2A mRNA, Glucosamine results in decreased expression of MEF2A protein CTD PMID:20165829 beta-D-glucosamine multiple interactions ISO RGD:1322126 6480464 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA] more ... CTD PMID:20165829 bis(2-chloroethyl) sulfide increases expression ISO RGD:1621608 6480464 Mustard Gas results in increased expression of MEF2A mRNA CTD PMID:15674843 , PMID:18955075 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MEF2A mRNA CTD PMID:29097150 , PMID:32145629 bisphenol A increases methylation ISO RGD:1322126 6480464 bisphenol A results in increased methylation of MEF2A gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MEF2A mRNA CTD PMID:30816183 more ... bisphenol A increases expression ISO RGD:1322126 6480464 bisphenol A results in increased expression of MEF2A mRNA CTD PMID:29275510 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of MEF2A mRNA CTD PMID:33453195 cadmium dichloride increases expression ISO RGD:1322126 6480464 Cadmium Chloride results in increased expression of MEF2A mRNA CTD PMID:26472689 caffeine multiple interactions EXP 6480464 Dantrolene inhibits the reaction [Caffeine results in increased expression of MEF2A mRNA], Dantrolene inhibits the reaction [Caffeine results in increased expression of MEF2A protein] CTD PMID:25093688 caffeine increases expression EXP 6480464 Caffeine results in increased expression of MEF2A mRNA, Caffeine results in increased expression of MEF2A protein CTD PMID:25093688 carbamazepine affects expression ISO RGD:1322126 6480464 Carbamazepine affects the expression of MEF2A mRNA CTD PMID:24752500 CGP 52608 multiple interactions ISO RGD:1322126 6480464 CGP 52608 promotes the reaction [RORA protein binds to MEF2A gene] CTD PMID:28238834 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of MEF2A mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:1621608 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MEF2A gene CTD PMID:20938992 cocaine increases expression EXP 6480464 Cocaine results in increased expression of MEF2A mRNA CTD PMID:17898221 coumestrol multiple interactions ISO RGD:1322126 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MEF2A mRNA CTD PMID:19167446 coumestrol decreases expression ISO RGD:1322126 6480464 Coumestrol results in decreased expression of MEF2A mRNA CTD PMID:19167446 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of MEF2A mRNA CTD PMID:26577399 cyclosporin A increases expression ISO RGD:1322126 6480464 Cyclosporine results in increased expression of MEF2A mRNA CTD PMID:20106945 cyclosporin A decreases methylation ISO RGD:1322126 6480464 Cyclosporine results in decreased methylation of MEF2A promoter CTD PMID:27989131 dantrolene multiple interactions EXP 6480464 Dantrolene inhibits the reaction [Caffeine results in increased expression of MEF2A mRNA], Dantrolene inhibits the reaction [Caffeine results in increased expression of MEF2A protein] CTD PMID:25093688 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of MEF2A mRNA CTD PMID:21266533 diclofenac affects expression ISO RGD:1322126 6480464 Diclofenac affects the expression of MEF2A mRNA CTD PMID:24752500 dimethylselenide multiple interactions ISO RGD:1322126 6480464 [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of MEF2A mRNA CTD PMID:33656867 dioxygen increases expression ISO RGD:1322126 6480464 Oxygen deficiency results in increased expression of MEF2A mRNA CTD PMID:26516004 dorsomorphin multiple interactions ISO RGD:1322126 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1322126 6480464 Doxorubicin results in increased expression of MEF2A mRNA CTD PMID:16001973 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MEF2A mRNA CTD PMID:31464424 enniatin decreases expression EXP 6480464 enniatins results in decreased expression of MEF2A mRNA CTD PMID:27163883 Enterolactone multiple interactions ISO RGD:1322126 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MEF2A mRNA CTD PMID:19167446 ethanol affects splicing ISO RGD:1621608 6480464 Ethanol affects the splicing of MEF2A mRNA CTD PMID:30319688 folic acid multiple interactions ISO RGD:1621608 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MEF2A gene CTD PMID:20938992 folic acid decreases expression ISO RGD:1621608 6480464 Folic Acid deficiency results in decreased expression of MEF2A, Folic Acid results in decreased expression of MEF2A mRNA CTD PMID:25384423 , PMID:25629700 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MEF2A mRNA CTD PMID:33387578 geraniol increases expression ISO RGD:1322126 6480464 geraniol results in increased expression of MEF2A mRNA CTD PMID:27683099 hydrogen cyanide decreases expression ISO RGD:1621608 6480464 Hydrogen Cyanide results in decreased expression of MEF2A mRNA CTD PMID:33914522 L-methionine multiple interactions ISO RGD:1621608 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MEF2A gene CTD PMID:20938992 lead diacetate affects expression ISO RGD:1621608 6480464 lead acetate affects the expression of MEF2A mRNA CTD PMID:21829687 leflunomide increases expression ISO RGD:1322126 6480464 leflunomide results in increased expression of MEF2A mRNA CTD PMID:28988120 metformin increases expression ISO RGD:1322126 6480464 Metformin results in increased expression of MEF2A mRNA CTD PMID:15864539 methylmercury chloride increases expression ISO RGD:1621608 6480464 methylmercuric chloride results in increased expression of MEF2A mRNA CTD PMID:29104120 methylmercury chloride decreases expression ISO RGD:1322126 6480464 methylmercuric chloride results in decreased expression of MEF2A mRNA CTD PMID:28001369 metoprolol multiple interactions EXP 6480464 Metoprolol inhibits the reaction [[[PPARGC1A protein results in increased expression of MEF2A mRNA] co-treated with [PPARGC1A protein results in increased expression of PPARA mRNA]] results in increased expression of CPT1B protein], Metoprolol inhibits the reaction [MEF2A protein binds to CPT1B promoter] CTD PMID:19233164 nickel atom affects expression ISO RGD:1322126 6480464 Nickel affects the expression of MEF2A mRNA CTD PMID:14575637 nickel atom multiple interactions ISO RGD:1322126 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of MEF2A mRNA] CTD PMID:14575637 nitric oxide decreases expression ISO RGD:1621608 6480464 Nitric Oxide deficiency results in decreased expression of MEF2A mRNA CTD PMID:15878706 oxytocin multiple interactions ISO RGD:1322126 6480464 MEF2A protein promotes the reaction [Oxytocin results in increased expression of KLF4 mRNA], MEF2A protein promotes the reaction [Oxytocin results in increased expression of KLF4 protein] CTD PMID:29104011 ozone multiple interactions ISO RGD:1322126 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of MEF2A mRNA more ... CTD PMID:32699268 paracetamol increases expression ISO RGD:1322126 6480464 Acetaminophen results in increased expression of MEF2A mRNA CTD PMID:26690555 , PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of MEF2A mRNA CTD PMID:33387578 phenobarbital affects expression ISO RGD:1621608 6480464 Phenobarbital affects the expression of MEF2A mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO RGD:1322126 6480464 Phenylmercuric Acetate results in decreased expression of MEF2A mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1322126 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEF2A mRNA CTD PMID:27188386 propiconazole decreases expression ISO RGD:1621608 6480464 propiconazole results in decreased expression of MEF2A mRNA CTD PMID:21278054 raloxifene multiple interactions ISO RGD:1322126 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of MEF2A mRNA CTD PMID:19059307 reactive oxygen species multiple interactions ISO RGD:1322126 6480464 [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of MEF2A mRNA CTD PMID:33656867 S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression ISO RGD:1621608 6480464 Buthionine Sulfoximine results in increased expression of MEF2A mRNA CTD PMID:15878706 SB 431542 multiple interactions ISO RGD:1322126 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenate increases expression ISO RGD:1621608 6480464 sodium arsenate results in increased expression of MEF2A mRNA CTD PMID:21795629 , PMID:30953684 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of MEF2A mRNA, sodium arsenite results in increased expression of MEF2A protein CTD PMID:25089838 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of MEF2A mRNA CTD PMID:35314868 sodium arsenite increases expression ISO RGD:1621608 6480464 sodium arsenite results in increased expression of MEF2A mRNA CTD PMID:36209798 succimer multiple interactions ISO RGD:1621608 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MEF2A mRNA CTD PMID:21641980 sulfates multiple interactions ISO RGD:1322126 6480464 [Soot co-treated with Sulfates] affects the methylation of MEF2A promoter CTD PMID:25395096 tamoxifen multiple interactions ISO RGD:1322126 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of MEF2A mRNA CTD PMID:19059307 tauroursodeoxycholic acid multiple interactions ISO RGD:1322126 6480464 ursodoxicoltaurine inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA], ursodoxicoltaurine inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein] CTD PMID:20165829 tauroursodeoxycholic acid multiple interactions EXP 6480464 ursodoxicoltaurine inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA], ursodoxicoltaurine inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein] CTD PMID:20165829 theophylline decreases expression ISO RGD:1322126 6480464 Theophylline results in decreased expression of MEF2A mRNA CTD PMID:18951874 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MEF2A mRNA CTD PMID:34492290 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of MEF2A mRNA CTD PMID:25729387 torcetrapib increases expression ISO RGD:1322126 6480464 torcetrapib results in increased expression of MEF2A mRNA CTD PMID:23228038 trichostatin A multiple interactions ISO RGD:1322126 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of MEF2A mRNA] CTD PMID:14575637 triptonide decreases expression ISO RGD:1621608 6480464 triptonide results in decreased expression of MEF2A mRNA CTD PMID:33045310 urethane increases expression ISO RGD:1322126 6480464 Urethane results in increased expression of MEF2A mRNA CTD PMID:28818685 valproic acid decreases methylation ISO RGD:1322126 6480464 Valproic Acid results in decreased methylation of MEF2A gene CTD PMID:29154799 valproic acid increases methylation ISO RGD:1322126 6480464 Valproic Acid results in increased methylation of MEF2A gene CTD PMID:28853863 , PMID:29201983 valproic acid multiple interactions ISO RGD:1322126 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEF2A mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1322126 6480464 Valproic Acid results in decreased expression of MEF2A mRNA CTD PMID:23179753 more ... vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of MEF2A mRNA CTD PMID:19015723 vorinostat decreases expression ISO RGD:1322126 6480464 vorinostat results in decreased expression of MEF2A mRNA CTD PMID:27188386 zinc atom multiple interactions ISO RGD:1322126 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of MEF2A mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1322126 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of MEF2A mRNA CTD PMID:18593933
